Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients

Critical Care Medicine

Volumn 39, Issue 1, 2011, Pages 40-45

  Hsieh, S Jean ^a,b   Ware, Lorraine B ^c   Eisner, Mark D ^a,b   Yu, Lisa ^b   Jacob, Peyton ^b   Havel, Christopher ^b   Goniewicz, MacIej L ^a,b   Matthay, Michael A ^a,b   Benowitz, Neal L ^a,b   Calfee, Carolyn S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

biomarkers; cigarette smoking; cotinine; critically ill; NNAL

Indexed keywords

3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; BIOLOGICAL MARKER; CIGARETTE SMOKE; COTININE; NICOTINE; TOBACCO SMOKE; TRANS 3' HYDROXYCOTININE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HAIR ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SMOKING; URINE LEVEL;

EID: 78651241449     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181fa4196     Document Type: Article

References (31)

1. U.S. Department of Health and Human Services: The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General, 2006. Atlanta, GA, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006
2. U.S. Department of Health and Human Services: The Health Consequences of Smoking: A Report of the Surgeon General, 2004. Atlanta, GA, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Of- fice on Smoking and Health, 2004
3. Flouris AD, Metsios GS, Carrillo AE, et al: Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am J Respir Crit Care Med 2009;179:1029-1033
4. World Health Organization: The Tobacco Atlas. Available at: http://www.who.int/tobacco/resources/publications/tobacco-atlas/en/index. html. Accessed August 21, 2009.
5. Centers for Disease Control and Prevention: Currrent cigarette smoking among adults 18 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:1135-1140
6. Centers for Disease Control and Prevention: Vital Signs: Nonsmokers' exposure to secondhand smoke-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2010;59: 1141-1146
7. Shipton D, Tappin DM, Vadiveloo T, et al: Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: A retrospective, cross sectional study. BMJ 2009;339:b4347
8. Gorber SC, Schofield-Hurwitz S, Hardt J, et al: The accuracy of self-reported smoking: A systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009;11: 12-24
9. Mant J, Murphy M, Rose P, et al: The accuracy of general practitioner records of smoking and alcohol use: Comparison with patient questionnaires. J Public Health Med 2000;22:198-201
10. Benowitz NL, Bernert JT, Caraballo RS, et al: Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009;169:236-248
11. Eisner MD, Jacob P 3rd, Benowitz NL, et al: Longer term exposure to secondhand smoke and health outcomes in COPD: Impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanol. Nicotine Tob Res 2009;11: 945-953
12. Goniewicz ML, Havel CM, Peng MW, et al: Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 2009;18:3421-3425
13. Benowitz NL, Hukkanen J, Jacob P 3rd: Nicotine chemistry, metabolism, kinetics and biomarkers. Hand Exp Pharmacol 2009;192: 29-60
14. Goniewicz M, Peyton J, Havel C, et al: Application of urine cotinine to NNAL ratio in tobacco smoke exposure assessment. Dublin, Ireland, 2009 Joint Conference of Society for Research on Nicotine and Tobacco and SNRT-Europe: Poster Session Abstracts:132. Available at: http://www.srnt.org/conferences/ past/2009/pdf/2009-Poster-Sessions.pdf. Accessed October 11, 2010
15. Copeland KT, Checkoway H, McMichael AJ, et al: Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-495
16. SRNT Subcommittee on Biochemical Verifi- cation: Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4:149-159
17. Shorr AF, Scoville SL, Cersovsky SB, et al: Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 2004;292:2997-3005
18. Iribarren C, Jacobs DR Jr, Sidney S, et al: Cigarette smoking, alcohol consumption, and risk of ARDS: A 15-year cohort study in a managed care setting. Chest 2000;117: 163-168
19. Benowitz NL, Schultz KE, Haller CA, et al: Prevalence of smoking assessed biochemically in an urban public hospital: A rationale for routine cotinine screening. Am J Epidemiol 2009;170:885-891
20. Office of Policy, Planning and Assessment: Prevalence of tobacco use in Tennessee, 1997-2007. Nashville, TN, Tennessee Department of Health, 2008
21. Centers for Disease Control and Prevention: Cigarette smoking among adults-United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57:1221-1226
22. Fidler JA, Jarvis MJ, Mindell J, et al: Nicotine intake in cigarette smokers in England: Distribution and demographic correlates. Cancer Epidemiol Biomarkers Prev 2008;17: 3331-3336
23. Substance Abuse and Mental Health Services Administration: Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD, Office of Applied Studies, 2008, NSDUH Series H-34, DHHS Publication SMA 08-4343
24. Heyman KM BP, Schiller JS: Early release of selected estimates based on data from the 2008 National Health Interview Survey. National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/nhis.htm. Accessed June 2009
25. Pirkle JL, Bernert JT, Caudill SP, et al: Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect 2006;114:853-858
26. Al-Delaimy WK, Willett WC: Measurement of tobacco smoke exposure: Comparison of toenail nicotine biomarkers and self-reports. Cancer Epidemiol Biomarkers Prev 2008;17: 1255-1261
27. Eisner MD, Klein J, Hammond SK, et al: Directly measured second hand smoke exposure and asthma health outcomes. Thorax 2005;60:814-821
28. Benowitz NL, Perez-Stable EJ, Fong I, et al: Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 1999;291:1196-1203
29. Jacob P 3rd, Havel C, Lee DH, et al: Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography- tandem mass spectrometry. Anal Chem 2008;80:8115-8121
30. Curfman GD, Morrissey S, Drazen JM: Tobacco, public health, and the FDA. N Engl J Med 2009;361:402-403
31. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985;13: 818-829